Literature DB >> 10411907

The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products.

C M Story1, M H Furman, H L Ploegh.   

Abstract

The US2 and US11 glycoproteins of human cytomegalovirus facilitate destruction of MHC class I heavy chains by proteasomal proteolysis through acceleration of endoplasmic reticulum-to-cytosol dislocation. Modification of the class I heavy chain was used to probe the structural requirements for this sequence of reactions. The cytosolic domain of the class I heavy chain is required for dislocation to the cytosol and for its subsequent destruction. However, interactions between US2 or US11 and the heavy chain are maintained in the absence of the class I cytosolic domain, as shown by chemical crosslinking in vivo and coprecipitation when translated in vitro. Thus, substrate recognition and accelerated destruction of the heavy chain, as facilitated by US2 or US11, are separable events.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411907      PMCID: PMC17548          DOI: 10.1073/pnas.96.15.8516

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  What drives the translocation of proteins?

Authors:  S M Simon; C S Peskin; G F Oster
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Peptide-binding specificity of the molecular chaperone BiP.

Authors:  G C Flynn; J Pohl; M T Flocco; J E Rothman
Journal:  Nature       Date:  1991-10-24       Impact factor: 49.962

3.  Expression of the W6/32 HLA epitope by cells of rat, mouse, human and other species: critical dependence on the interaction of specific MHC heavy chains with human or bovine beta 2-microglobulin.

Authors:  W A Jefferies; G G MacPherson
Journal:  Eur J Immunol       Date:  1987-09       Impact factor: 5.532

4.  Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules.

Authors:  M A Vega; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Control of topology and mode of assembly of a polytopic membrane protein by positively charged residues.

Authors:  G von Heijne
Journal:  Nature       Date:  1989-10-05       Impact factor: 49.962

6.  The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol.

Authors:  E J Wiertz; T R Jones; L Sun; M Bogyo; H J Geuze; H L Ploegh
Journal:  Cell       Date:  1996-03-08       Impact factor: 41.582

7.  Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.

Authors:  P Parham; C J Barnstable; W F Bodmer
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

8.  ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway.

Authors:  M M Hiller; A Finger; M Schweiger; D H Wolf
Journal:  Science       Date:  1996-09-20       Impact factor: 47.728

9.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

10.  Assembly of ER-associated protein degradation in vitro: dependence on cytosol, calnexin, and ATP.

Authors:  A A McCracken; J L Brodsky
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

View more
  31 in total

1.  Identification of a membrane targeting and degradation signal in the p42 protein of influenza C virus.

Authors:  A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Polyubiquitination is required for US11-dependent movement of MHC class I heavy chain from endoplasmic reticulum into cytosol.

Authors:  C E Shamu; D Flierman; H L Ploegh; T A Rapoport; V Chau
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

3.  Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein.

Authors:  J M Johnson; C Nicot; J Fullen; V Ciminale; L Casareto; J C Mulloy; S Jacobson; G Franchini
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 4.  In vivo immunogenetics: from MIC to RAET1 loci.

Authors:  Mirjana Radosavljevic; Seiamak Bahram
Journal:  Immunogenetics       Date:  2003-03-20       Impact factor: 2.846

Review 5.  Lessons from viral manipulation of protein disposal pathways.

Authors:  Margo H Furman; Hidde L Ploegh
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

6.  Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking.

Authors:  Maya Williams; Jeremiah F Roeth; Matthew R Kasper; Rebekah I Fleis; Chris G Przybycin; Kathleen L Collins
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 7.  The MHC class I antigen presentation pathway: strategies for viral immune evasion.

Authors:  Eric W Hewitt
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

8.  Requirements for the selective degradation of endoplasmic reticulum-resident major histocompatibility complex class I proteins by the viral immune evasion molecule mK3.

Authors:  Xiaoli Wang; Rose Connors; Michael R Harris; Ted H Hansen; Lonnie Lybarger
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

9.  Dislocation of a type I membrane protein requires interactions between membrane-spanning segments within the lipid bilayer.

Authors:  Brendan N Lilley; Domenico Tortorella; Hidde L Ploegh
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

10.  MHC class I molecules are preferentially ubiquitinated on endoplasmic reticulum luminal residues during HRD1 ubiquitin E3 ligase-mediated dislocation.

Authors:  Marian L Burr; Dick J H van den Boomen; Helen Bye; Robin Antrobus; Emmanuel J Wiertz; Paul J Lehner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.